The Academy of Pharmaceutical Sciences
'Promoting the Pharmaceutical Sciences'
Member Login        


  3rd Annual MIBio Conference - 29th October 2013, Fitzwilliam College, Cambridge University ...      Have you read this article "Towards Global Stability Protocols: A Decade of Lost Opportunities?" ...      APS Biopharmaceutics Applied biopharmaceutics - understanding bioequivalence, biowavers and IVIVCs ...      SME showcase at APS PharmSci 2013 ...      Prof Dame Janet Thornton, DBE, FRS confirmed as a plenary speaker at PharmSci 2013...      Skills and Training in Formulation Technology – Developing People for Business Success...      London BioNat Network Research Meeting...      APS Medicines for Older Adults...     
Home My Account About Us Join Us Events Focus Groups The Board Awards Sponsorship Useful Links
Focus Groups
[Group Library] (members only)

Aims and Objectives

  • Focus group within the Academy of Pharmaceutical Sciences open to all members with an interest in pulmonary and nasal drug delivery.
  • Provide a forum for Industry, Academe and the Regulators to engage in discussion of current issues in science, technology & regulation pertinent to pulmonary and nasal drug delivery.
  • Collaborate and coordinate with other relevant organizations active in the field (e.g. Aerosol Society (DDL), EPAG, AAPS,HESI and RDD) with a view to establishing joint meetings and dialogue in the field.
  • Provide continuing education for the membership via for e.g. a biennial symposium, interim focussed workshops/seminars.

Focus Group Steering Committee

  • Eddie French (Chair), TEKH Consulting Ltd
  • Ben Forbes, King’s College London
  • Darragh Murnane, University of Hertfordshire
  • Jeremy Clarke, GlaxoSmithKline
  • John Pritchard, Phillips Respironics
  • Joe Takher-Smith, Mylan Global Respiratory Group
  • Nayna Govind, NG Pharma Consulting Ltd
  • Philippe Rogueda, Watson Pharmaceuticals
  • Rob Price, University of Bath

Drugs in the Lungs NETWORK (update with output from DDL 2012)

  • The Drugs in the Lung Network was devised with the aim of providing cross-company collaboration and developing industry-academia pre competitive consortia.
  • The Network aims to provide supportive for a for technical and scientific (i.e. data rich) discussions with the aim of advancing the knowledge of early - to late stage inhaled product development.
  • For more news see the paper from the June 2013 issue of Inhalation Magazine

Upcoming Events

  • UKPharmSci Inhaled 1 (Session 3.31) Wed 4 Sept: New technologies to enable respiratory medicines
  • UKPharmSci Inhaled 2 (Session 3.32) Wed 4 Sept: Current thinking on the impact of mucus on drug in the lungs

Previous Events

  • Inhalation 2007, 2009, 2011
  • Drugs in the Lungs NETWORK – click here

Areas of Interest

  • Inhalation biopharmaceutics
  • Pulmonary therapeutics
  • Particle production technologies
  • Drug delivery technologies
  • Formulation technologies
  • Novel technologies and methods to understand, control, predict and improve drug product performance, processability and stability.
  • In vitro characterisation techniques

Copyright ©2008-2013 The Academy of Pharmaceutical Sciences
Q House, Troon Way Business Centre, Humberstone Lane, Thurmaston, Leicester, LE4 9HA, Tel: 0116 274 7351, Fax: 0116 274 7365, Email: [email protected]